REPL::Rights::Voluntary

Issuer & Securities

Issuer/ Manager: IX BIOPHARMA LTD.
Security: IX BIOPHARMA LTD. - SG1BD9000009 - 42C

Announcement Details

Announcement Title: Listing and Quotation
Date &Time of Broadcast: 22-Jul-2024 19:57:26
Status: Replacement
Corporate Action Reference: SG240606RHDIEF9M
Submitted By (Co./ Ind. Name): Gwendolin Lee Soo Fern
Designation: Company Secretary
Event Status: Pending Listing Announcement
Underwritten: No
Shareholders' Approval Required?: No
Shareholders' Approval Obtained: No
Financial Year End: 30/06/2024
Foreign Shareholder Eligibility: No

Event Narrative

Narrative Type	Narrative Text
Additional Text	Proposed Renounceable Non-Underwritten Rights cum Warrants Issue

Dates

Record Date: 26/06/2024
Ex Date: 25/06/2024

Rights Details

Rights Security ISIN: SGXN29528811
Rights Security Name: IX BIOPHARMA LTD. R
Security Not Found?: No
Renounceable: Yes
Trading Period From: 01/07/2024
Trading Period To: 09/07/2024
Rights Security Distribution Ratio- Underlying: 50
Rights Security Distribution Ratio- Rights Security: 11

Attachment for Listing

iX - Repl Ann - Allotment of Rights Shares and Warrants - Final.pdf

Option Exercise

Issue Price (Per Rights): SGD 0.03
Exercise Period: 01/07/2024 TO 15/07/2024

Renounceable Conditions

Allow Over Subscription: Yes

Attachments

iX - Announcement - Launch of RI - final.pdf

iX Biopharma Ltd - Ann on OIS.pdf

iX Biopharma Ltd - Offer Info Statement 26 Jun 2024.pdf

iX - Announcement - LQN - final.pdf

iX - Announcement - Record Date - final.pdf

iX - Repl Ann - Allotment of Rights Shares and Warrants - Final.pdf

Total size =2669K

Related Announcements

Related Announcements: 26/06/2024 18:26:40
18/06/2024 17:53:51
11/06/2024 12:04:42
06/06/2024 18:46:42